A system for managing female incontinence includes a body of biocompatible material configured to fit between the labia minora and the vestibule floor, the body having a surface configured to occlude the urethral meatus, an adhesive carried on at least a first portion of the surface and configured to provide a sealing engagement between the body and the urethral meatus, and a substance carried by at least one of the body and the adhesive and configured for controlling the odor of the general vaginal-urethral area of a female.

An absorbent member (20) includes an absorbent sheet (10) in which absorbent polymer (12) is fixed to a base sheet (11) and a cover sheet (21) covering at least a first surface of the absorbent sheet (10). The absorbent sheet (10) has an absorbent polymer fixing proportion of 40% or more. The absorbent member (20) has high fixing performance of the absorbent polymer (12) to the base sheet (11) and is less likely to suffer from detachment of the absorbent polymer (12) even after liquid absorption. The absorbent polymer (12) is preferably fixed to the base sheet (11) with a base sheet fixing adhesive (13) interposed therebetween. The adhesive (13) is preferably an acrylic, silicone-based or rubber-based adhesive, and is preferably a hot-melt adhesive.

A laminate patchable a living body includes a pressure-sensitive adhesive layer for patching to the living body and a substrate layer disposed on a one-side surface in a thickness direction of the pressure-sensitive adhesive layer and supporting the pressure-sensitive adhesive layer. The pressure-sensitive adhesive layer contains a first carboxylic acid ester and the substrate layer contains a second carboxylic acid ester.

A garment using a phase change material that change phase from solid to liquid at a low or high temperatures situated within a gel matrix. The phase change material may be used after surgical procedures to reduce swelling, edema and bruising. The gel matrix allows the material of the present invention to maintain a conformable and elastic form at room temperature. This invention provides the novelty of a low or high temperature phase change material that is conformable to surfaces or volumes of varying geometry.

The invention relates to a medical product for a fastening duration of at least 7 days having good skin compatibility. The medical product includes a central adhesive compartment (3) and an over-patch. The over-patch is free of active ingredients and is formed from a water-vapor-permeable back layer (1) and an adhesive polymer layer (2) that is free of active ingredients. The invention further relates to a method for the production of the foregoing medical product, and to kits of parts containing laminates of layers 1 and 2.

The invention relates to a medical product for a fastening duration of at least 7 days having good skin compatibility. The medical product includes a central adhesive compartment (3) and an over-patch. The over-patch is free of active ingredients and is formed from a water-vapor-permeable back layer (1) and an adhesive polymer layer (2) that is free of active ingredients. The invention further relates to a method for the production of the foregoing medical product, and to kits of parts containing laminates of layers 1 and 2.

The present disclosure relates to a medical dressing comprising a carrier material and a composite material. The composite material comprises oil droplets dispersed in a matrix. The matrix comprises one or more cellulose derivatives and nanocellulose.

The present disclosure relates to a medical dressing comprising a carrier material and a composite material. The composite material comprises oil droplets dispersed in a matrix. The matrix comprises one or more cellulose derivatives and nanocellulose.

The subject matter of the present invention is, according to a first aspect, a dressing comprising an interface layer, characterised in that said interface layer comprises a weave coated with an elastomeric matrix comprising metformin, the salts and the complexes thereof. The subject matter of the invention is also a dressing comprising metformin, characterised in that the percentage of metformin released after 72 hours is between 40 and 100% of the quantity of metformin inserted in the dressing. Moreover, the subject matter of the invention is a method for producing said dressing as well as the use thereof for healing a wound.

The subject matter of the present invention is, according to a first aspect, a dressing comprising an interface layer, characterised in that said interface layer comprises a weave coated with an elastomeric matrix comprising metformin, the salts and the complexes thereof. The subject matter of the invention is also a dressing comprising metformin, characterised in that the percentage of metformin released after 72 hours is between 40 and 100% of the quantity of metformin inserted in the dressing. Moreover, the subject matter of the invention is a method for producing said dressing as well as the use thereof for healing a wound.